Interpace Biosciences holds annual stockholder meeting
IDXG•Annual meeting approvals
Interpace Biosciences held its 2026 annual stockholders meeting on Aug. 20, 2026.
- Stockholders adopted an amended and restated certificate of incorporation.
- Investors authorized the board to amend the charter to execute a reverse stock split, if pursued, at a 1-for-2 to 1-for-10 ratio.
- Approval was also secured for the 2026 Equity Incentive Plan.
- Stockholders adopted the 2026 Employee Stock Purchase Plan.
